Heme oxygenase-1 levels increase during erythroid differentiation.
Introduction
Heme is a complex of iron with protoporphyrin IX that is essential for the function of all aerobic cells. Heme serves as the prosthetic group of numerous hemoproteins (e.g., hemoglobin, myoglobin, cytochromes, guanylate cyclase, and nitric oxide synthase) and plays an important role in controlling protein synthesis and cell differentiation 1 . However, when left unguarded, non-protein-bound heme promotes free radical formation and lipid peroxidation, resulting in cell damage and tissue injury 2, 3 . Hence, cellular heme levels are tightly controlled; this is achieved by a fine balance between heme biosynthesis and catabolism.
The highest amounts of organismal heme (75-80%) are present in circulating RBC whose precursors synthesize heme with rates that are at least one order of magnitude higher than those in the liver, the second most active heme producer in mammals. Differences in iron metabolism and in the genes encoding 5-aminolevulinic acid synthase (ALA-S, the first enzyme in heme biosynthesis) are responsible for the variation in the regulation and rates of heme synthesis in erythroid and non-erythroid cells 1 .
Heme is degraded by heme oxygenases (HO) yielding iron, bilirubin and carbon monoxide 4, 5 . Heme from RBC is fated to be catabolized in splenic and hepatic macrophages, following erythrophagocytosis of senescent RBC. There are two isoforms of heme oxygenases, HO-1 and HO-2. The constitutive form, HO-2, is membrane-bound protein found at highest levels in the brain and testis 6 . The inducible form, HO-1, is a 32.8 kDa membrane-bound enzyme found at highest concentrations in the liver and spleen. HO-1 is increased in animal tissues after treatment with its natural substrate heme, as well as various metals, xenobioticis, endocrine factors, and synthetic metalloporphyrins 6 as well as several agents that cause oxidative damage
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For personal use only. on October 31, 2017. by guest www.bloodjournal.org From line available, we used primary erythroid cells from control and HO-1 -/-mice whenever possible.
Livers from appropriate animals were processed as described below. For reticulocytes studies, wild type (HO-1 +/+ ) and HO-1 knockout (HO-1 -/-) mice were injected for 3 days with phenylhydrazine (25 mg/kg). After two days of rest, the mice were sacrificed and the blood was collected by cardiac puncture. Thiazol Orange staining was performed to determine the percentage of reticulocytes in both HO-1 +/+ and HO-1 -/-samples 11 . The percentage of reticulocytes determined by thiazol orange staining was used to normalize the results.
Cell culture and chemicals
In experiments where primary cells would not suffice, we settled for using MEL cells. MEL cells were cultured as described in the Supplemental Information (SI). All the experiments were conducted with both uninduced MEL cells (0h) as well as cells treated with 1.8% DMSO (Me 2 SO 2 ) to induce differentiation and hemoglobinization 12 . Primary erythroid cells were cultured as described 13 . Briefly, cells were grown from fetal livers that were obtained from E12.5 embryos of wild-type and HO-1 knockout (FVB.129[B6] background) mice. Primary fetal liver cells were either kept in undifferentiated state (0h) or induced to terminal differentiation (24, 48 or 72h) . The medium composition to maintain the cells in such states are described in further detail in the SI. Where indicated, cells were treated with 100µM of the HO-1 inhibitor, tin-protoporphyrin IX (SnPP) (Frontier Scientific, Logan, USA) and 0.4mM of heme synthesis inhibitor, succinyl acetone (SA) (Sigma, St Louis, USA).
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From
MEL cells stable transfection
We generated MEL cells that overexpress HO-1 as described in the SI. MEL cell clones showing highest levels of HO-1 expression (MELHO-1) were used in the experiments. MEL cells clones carrying only the plasmid, without HO-1 cDNA insert, were used as control.
Cell membrane transferrin receptor (TfR) detection
Non-differentiated and differentiated cells were washed twice with PBS/2% fetal calf serum (FCS) and stained with fluorescence-labeled antibodies against transferrin receptor (CD71-FITC; PharMingen, San Diego, CA). Surface marker expression was analyzed by flow cytometry (FACSCalibur; BD Biosciences, Mississauga, Canada) as shown in Supplemental Figure S1 .
Geometric means were used to quantify the changes in TfR expression in the different conditions tested.
Ter119-and Ter119+ cell sorting
Femora and humeri from wild type mice were collected and their bone marrows extracted. Bone marrow cells were processed following the protocol described in the SI. Ter119-and Ter119+ cells were sorted by flow cytometry (FACSVantage SE; BD Biosciences, Mississauga, Canada).
Heme and hemoglobin assay
Cellular heme content was assayed as described previously 14 . The experiment results were normalized by protein concentration. Hemoglobin assay was performed as previously 15, 16 . The quantification results were normalized by cell number and cell volume. Both protocols are described in detail in the SI. 
Statistical analysis
Statistical analysis was done using the software SPSS v15.0 (IBM Software, Markham, Canada).
Data was evaluated applying ANOVA and Student's t tests. Error bars of graphs represent the standard deviation of three independent experiments (n=3).
Results

HO-1 mRNA and protein are highly expressed in the bone marrow Ter119+ cells
We used the erythroid marker Ter119 17 to isolate erythroid cells from mouse bone marrow using FACS. As expected, Ter119+ cells showed high expression of globin mRNA and protein, indicating their erythroid origin ( Figure 1A and C). We also found that HO-1 mRNA ( Figure 1B) and protein ( Figure 1C ) expressions were increased 20-fold and 2.5-fold, respectively in Ter119+ cells (representing all cells of erythroid lineage) as compared to Ter119-cells (representing the bone marrow-derived, non-erythroid cells).
HO-1 mRNA and protein levels increase during erythroid differentiation of FL cells
Using primary erythroid cells isolated from mouse fetal livers (FL) at 12.5 days, we evaluated HO-1 mRNA levels during EPO-induced erythroid differentiation. As shown in Figure 1D , HO-1 mRNA levels significantly increase during 48h and 72h of differentiation. Hence, we examined whether heme, whose synthesis is well-known to increase throughout erythroid differentiation 1 , could be involved in the enhancement of expression of HO-1 in the differentiating FL cells. We demonstrated ( Figure 1D ) that succinylacetone (SA), a specific inhibitor 18 of 5-aminolevulinic acid dehydratase (the second enzyme in heme biosynthesis), added 24h prior to cell harvest, blocked the increase in HO-1 mRNA expression at 48 and 72h. Moreover, the expression of HO- Figure 1E-F) . Thus, as in virtually all cell types 19 , heme induces HO-1 expression in erythroid cells.
HO-1 overexpression impairs globin expression and activates HRI in differentiating MEL cells
We were surprised that the upregulation of HO-1 expression observed in the above experiment ( Figures 1D-F ) did not interfere with hemoglobinization. To further examine this issue, we generated a MEL cell line stably over-expressing HO-1 (MELHO-1; see Material and Methods section). As shown in the Supplemental Figure S2 , MELHO-1 cells express 14-fold higher levels of HO-1 mRNA (Supplemental Figure S2A ) and 10-fold more HO-1 protein (Supplemental In erythroid precursors, heme acts as a translational regulator by modulating the activity of the heme-regulated eIF2α kinase, HRI 21 . During heme deficiency, HRI is active which in turn leads to the inhibition of globin translation. We demonstrated that after 48h of stimulation of erythroid differentiation (incubation with DMSO), MELHO-1 cells contained increased levels of eIF2α-P as compared to controls . This indicates that HO-1 overexpression
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HO-1 overexpression decreases transferrin receptor (TfR) levels and iron uptake in
DMSO-treated MEL cells
The rate of iron acquisition from transferrin limits and, therefore, controls the rate of heme synthesis in erythroid cells Fe into heme ( Figure 3C ).
HO-1 could interfere with the formation of heme and, therefore, we tested the integrity of heme biosynthesis by supplying cells with 59 Fe-salicylaldehyde isonicotinoyl hydrazone ( 59 Fe-SIH), a membrane permeable iron chelate that has the ability to supply iron for ferrochelatase [22] [23] [24] bypassing the physiological transferrin-TfR pathway. There was no difference in iron incorporation into heme between MELHO-1 and control cells, when the physiological iron delivery pathway was bypassed using 59 Fe-SIH ( Figure 3D ). Hence, these data indicate that HO-1 overexpression leads to a diminished iron supply for heme biosynthesis as a result of decreased TfR expression. Since in erythroid cells heme is needed for the maintaining of high rate of TfR Figure   S3 ). These data suggests only a small contribution, if any, of the IRE/IRP system to the reduction in TfR levels and the increase in ferritin levels in MELHO-1 cells ( Figures 3A-B Interestingly, FL/HO-1 -/-cell pellets exhibited a higher degree of redness than wild type cell pellets at 0h, 24h and 48h of differentiation ( Figure 4C ). Indeed, erythroid cells lacking HO-1 have a higher hemoglobin content, as determined by its direct measurement ( Figure 4D ).
Differentiating FL/HO-1 -/-cells show increased TfR and globin expression with a reduction in ferritin expression
As expected, we found that FL/HO-1 -/-cells express higher amounts of TfR mRNA, in particular at 24 and 48h ( Figure 5A ) and exhibit a slight increase in TfR protein levels ( Figure 5D -E). Flow cytometry analysis revealed an increase in TfR presence on the membrane of FL/HO-1 -/-cells, in particular at 0 and 24h following EPO treatment ( Figure 5B ). Figure 5C shows a significant increase in globin mRNA in FL/HO-1 -/-cells at 0 and 48h. The equal levels of globin mRNA at 24h can likely be explained by the presence of overriding, heme-independent transcription factors that drive globin gene expression during the early stages of differentiation in both cell types equally. FL/HO-1 -/-cells contain more globin protein ( Figure 5D -E), although the 1 1 differences in its levels are smaller than in the case of globin mRNAs. This probably indicates that translation is limiting in the overall process of globin gene expression. On the other hand, ferritin protein levels were reduced in FL/HO-1 -/-cells ( Figure 5D -E), suggesting that the increased flux of iron into heme leads to a decreased in ferritin translation. An additional factor that could cause a decrease in ferritin synthesis would be a decrease in "free" iron levels caused by HO-1 deficiency.
HO-1 -/-reticulocytes display increased TfR levels and iron uptake and contain lower levels of eIF2α phosphorylation.
Reticulocytes were isolated from both HO-1 +/+ and HO-1 -/-mice injected with phenylhydrazine.
When analyzed by flow cytometry, HO-1 -/-reticulocytes showed a significant increase in the levels of TfR present on the cell membrane ( Figure 6A ). Moreover, HO-1 -/-reticulocytes took up significantly more 59 Fe-Tf compared to HO-1 +/+ reticulocytes after 15 minutes of incubation ( Figure 6B ). Additionally, eIF2α-P levels were decreased in HO-1 -/-reticulocytes ( Figure 6C ), suggesting an increased heme level and consequent reduction in HRI activity. In agreement with that, globin protein levels were higher in HO-1 -/-reticulocytes compared to HO-1 +/+ ( Figure 6C ).
Discussion
Heme oxygenase 1 has been extensively studied in hepatocytes and other non-erythroid cells 4, 6, 26 . In contrast, the literature on HO-1 in erythroid cells is extremely scarce. It is quite surprising that there is so little known about the role of the enzyme that catabolizes heme (HO-1) in erythroid cells that make, by far, the most heme in mammals. We were able to identify only two rather non-instructive studies that examined HO-1 mRNA expression in erythroid cells 27, 28 .
Fujita and Sassa observed a decrease in HO-1 mRNA levels in the first 12h of differentiation at hemoglobin or, at least, earmarked for globin binding. This hypothesis is supported by our finding that hemoglobin and heme levels decrease in MELHO-1 cells (Figure 2A -B).
We deemed it important to also investigate iron metabolism indices and some aspects of Figure S4 ), but this difference is statistically significant only at 0h. At 0h and 48h of differentiation, globin mRNA expression was also significantly higher in FL/HO-1 -/-cells ( Figure 5C ); this increase was associated with enlarged globin protein levels ( Figure 5D -E).
These results suggest that an expansion of an "uncommitted" or "regulatory" heme pool leads to an increase in TfR levels (Figures 5A-B and D-E) and consequently enhanced globin expression (Figures 5C-E). Heme can be expected not only to promote the efficiency of globin translation 21,32 but also its transcription 33, 34 . Similarly, TfR levels and iron uptake were increased in HO-1 knockout reticulocytes ( Figures 6A and B) . We also observed a trend of increased iron incorporation into heme in HO-1 knockout reticulocytes compared to wild type reticulocytes ( Figure 6B ). Additionally, eIF2α-P levels were reduced in HO-1 knockout reticulocytes ( Figure   6C ). Therefore, the effects of HO-1 deficiency on erythroid iron metabolism and heme synthesis are preserved up to the very late stages of the terminal erythroid differentiation.
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Compared to control cells, ferritin protein expression is dramatically reduced in both nondifferentiated and differentiated FL/HO-1 -/-cells ( Figure 5D -E). This finding strongly suggests that in the absence of HO-1, there is a reduction in the cellular labile iron pool, highly likely as a result of increased heme stability.
It is important to note that HO-1-deficient mice developed anemia associated with abnormally low serum iron levels
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. of conditional erythroid-specific Hmox1 -/-mice with the aim to further asses the role of HO-1 in erythropoiesis.
The results reported here have important ramifications for our understanding of erythroid differentiation, both in normal and some pathological conditions. First, it has been proposed that most mammalian cells contain a "free" or "uncommitted" heme pool, serving both precursor and regulatory functions 1 . This study strengthens the idea that such a pool is present also in erythroid Second, the aberrant expression of HO-1 may play a role in the pathophysiology of thalassemia. In the normal assembly of adult hemoglobin (α 2 β 2 ), the synthesis of globin chains is very tightly coordinated. However, in β -thalassemia, production of β -globin decreases and excess α -globin accumulates; in α thalassemia this process occurs in reverse 44, 45 . Unpaired globin chains that accumulate in both types of thalassemic erythroblasts have heme molecules attached to them. α -subunits, which accumulate in β -thalassemia are highly unstable and susceptible to autoxidation, likely liberating their heme that would be expected to induce HO-1. Oxidative stress is a key pathogenic factor involved in damaging β -thalassemic erythroblasts 46 , which also exhibit a significantly higher level of apoptosis 47 . Indeed, we found that MELHO-1 cells generate significantly higher levels of reactive oxygen species (ROS) than control cells (Supplemental Figure S5A ) and display elevated apoptosis (Supplemental Figure S5B ) suggest
that elevated levels of HO-1 could play a role in the pathophysiology of β -thalassemic erythroblasts. Additionally, our finding of elevated apoptosis in MELHO-1 cells is congruent with an earlier report that the inhibition of heme synthesis induces apoptosis in human erythroid progenitor cells 48 . Additionally, membranes of β -thalassemic erythrocytes 49, 50 , and likely also erythroblasts, contain iron -a substrate for Fenton reaction -that can be derived from heme due to the enhanced activity of HO-1.
In conclusion, our results bring to light the importance of HO-1 expression for erythroid development and expand our knowledge about the fine regulation of hemoglobin synthesis in erythroid cells. Our results indicate that HO-1 plays an important role as a co-regulator of the erythroid differentiation process. Moreover, HO-1 expression must be tightly regulated during red blood cell development, since imbalance of its expression may lead to serious consequences for the hemoglobin biosynthesis pathway ( Figures 7A and B) . 
